Production and separation of non-carrier-added 86Y from enriched 86Sr targets

Applied Radiation and Isotopes

Volumn 66, Issue 1, 2008, Pages 9-13

  Avila Rodriguez, Miguel A ^a   Nye, Jonathon A ^b   Nickles, Robert J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Low energy cyclotron; Non carrier added separation; Yttrium 86; Yttrium 90 surrogate

Indexed keywords

LOW-ENERGY CYCLOTRONS; NON-CARRIER-ADDED SEPARATION; SURROGATES; YTTRIUM-86;

CYCLOTRONS; HELIUM; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; PHASE SEPARATION; PROTONS; STRONTIUM COMPOUNDS;

RADIOISOTOPES;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; HELIUM; PROTON; STRONTIUM; STRONTIUM 86; STRONTIUM CARBONATE; UNCLASSIFIED DRUG; YTTRIUM 86;

ARTICLE; CHEMICAL ANALYSIS; CYCLOTRON; FILTRATION; IRRADIATION; LOW ENERGY RADIATION; PRIORITY JOURNAL; SEPARATION TECHNIQUE;

CYCLOTRONS; MASS SPECTROMETRY; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; STRONTIUM ISOTOPES; YTTRIUM RADIOISOTOPES;

EID: 36049004884     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2007.07.027     Document Type: Article

References (19)

1. Avila-Rodriguez, M.A., Nye, J.A., Nickles, R.J., 2007. Simultaneous production of high specific activity Cu-64 and Co-61 with 11.4 MeV protons on enriched Ni-64 nuclei. Appl. Radiat. Isot. doi:10.1016/j.apradiso.2007.05.012.
2. Brockmann J., Rösch F., Herzog H., Mühlensiepen H., Köhle M., Stolz B., Marbach P., and Müller-Gärtner H.W. Complexation, in vivo-stability, blood clearance and excretion kinetics of 86Y-DOTA-Tyr3-octreotide in baboons. J. Label Compd. Radiopharm. 39 (1997) 468-470
3. Fichna J., and Janecka A. Synthesis of target-specific radiolabeled peptides for diagnostic imaging. Bioconjugate Chem. 14 (2003) 3-17
4. Finn R.D., McDevitt M., and Ma D.etal. Low energy cyclotron production and separation of Yttrium-86 for evaluation of monoclonal antibody pharmacokinetics and dosimetry. In: Duggan J.L., and Morgan I.L. (Eds). Applications of Accelerators in Research and Industry: Proceedings of the 15th International Conference (1999), AIP Press, Woodbury, NY 991-993
5. Förster G.J., Engelbach M., Brockmann J., Reber H., Buchholz H.-G., Mäcke H.R., Rösch F., Herzog H., and Bartenstein P. Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide. Eur. J. Nucl. Med. 28 (2001) 1743-1750
6. Friedlander J., Kennedy J.W., Macias E.S., and Miller J.M. Nuclear and radiochemistry. third ed. (1981), Wiley, New York p. 296
7. Herzog H., Rösch F., Stöcklin G., Lueders C., Qaim S.M., and Feinendegen L.E. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics. J. Nucl. Med. 34 (1993) 2222-2226
8. Lovqvist A., Humm J.L., Sheikh A., et al. PET imaging of (86)Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between (86)Y and (1 1 1)In radiolabels. J. Nucl. Med. 42 (2001) 1281-1287
9. 64Cu using a biomedical cyclotron. Nucl. Med. Biol. 24 (1997) 35-43
10. 124I]-iodine on an 11 MeV cyclotron. Radiochim. Acta 94 (2006) 213-216
11. Park L.S., Szajek L.P., Wong K.J., Plascjak P.S., Garmestani K., Googings S., Eckelman W.C., Carrasquillo J.A., and Paik C.H. Semi-automated 86Y purification using a three-column system. Nucl. Med. Biol. 31 (2004) 297-301
12. Reischl G., Rösch F., and Machula H.J. Electrochemical separation and purification of yttrium-86. Radiochim. Acta 90 (2002) 225-228
13. 3He,xn)-processes. Radiochim. Acta 61 (1993) 1-8
14. 86Y for nuclear medical application. Appl. Radiat. Isot. 44 (1993) 677-681
15. Rösch, F., Herzog, H., Neumaier, B., et al., 1996a. Quantitative whole-body pharmacokinetics of yttrium-86 complexes with PET and radiation dose calculation of analogous yttrium-90 radiopharmaceuticals. In: Stelson, A.T., Stabin, M.G., Sparks, R.B. (Eds.), Conference Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium, Gatlinburg, TN, pp. 101-110.
16. Rösch F., Herzog H., Plag C., Neumaier B., Braun U., Müller-Gärtner H.W., and Stöcklin G. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur. J. Nucl. Med. 23 (1996) 958-966
17. Rösch F., Herzog H., Stolz B., Brockmann J., Köhle M., Mühlensiepen H., Marbach P., and Müller-Gärtner H.W. Uptake kinetics of the somatostatin receptor ligand [86Y]DOTA-Dphe1-Tyr3-octreotide ([86Y]SMT 487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90Y-labelled analogue. Eur. J. Nucl. Med. 26 (1999) 358-366
18. 64Cu]Cu-ATSM for PET studies. Radiochim. Acta 93 (2005) 239-244
19. 86Y using a small biomedical cyclotron. Nucl. Med. Biol. 32 (2005) 891-897